Navigation Links
AcneHeroes.com Puts Focus on Skin Care for Prom
Date:4/21/2009

Web Site Teams Up with AnnaLynne McCord and Dr. Jeanine Downie to Provide Skin Care Tips and Expert Advice to Look and Feel Your Best by Prom Night

BRIDGEWATER, N.J., April 21 /PRNewswire-FirstCall/ -- AcneHeroes.com, a leading Web site that offers a wide array of information on acne and skin care, has teamed up with AnnaLynne McCord and renowned dermatologist, Dr. Jeanine Downie, to launch Skin Care for Prom to help teens get ready for one of the biggest events of the school year.

Acne is a challenge for many teens and can be especially difficult to deal with during social milestones. Skin Care for Prom, the newest addition to the site, is dedicated to offering tips ranging from skin care secrets to what to wear. AnnaLynne McCord, who plays Naomi Clark on the hit TV show 90210, has experienced acne breakouts and understands the importance of looking and feeling your best for special events.

"Prom is a time when teens want to look their best -- from head to toe -- and that includes their skin," says McCord. "Having acne has been a challenge for me as I'm sure it is for many teens. That's why I got involved with AcneHeroes.com -- I want to share my secrets for clear skin with teens across the country."

This innovative Web site offers a multitude of resources where teens and their parents can learn about acne from an expert and find AnnaLynne's skin care tips to look red-carpet ready for the prom. AcneHeroes.com also features a virtual Countdown to Prom calendar where Dr. Downie and AnnaLynne will share a tip-a-day for 30 days to help teens get ready for the big night.

"I treat a lot of teens who are dealing with the challenges of acne and looking for guidance before events such as the prom," says Dr. Downie, director of image Dermatology P.C. in Montclair, N.J. and co-author of Beautiful Skin of Color. "In addition to the Web site as a resource for teens, it is also important for parents to take an active role in helping their children seek appropriate treatment from a dermatologist."

Dr. Downie also suggests the following tips to maintain clear skin:

  • Talk to your parents -- If you have occasional breakouts, discuss scheduling an appointment with your dermatologist or pediatrician at least one month prior to prom night to find out about personalized skin care regimens and effective treatments that may be right for you.
  • Cover up -- Excessive sun exposure can damage the skin, remember to wear sunscreen.
  • Makeup rules -- Use water-based products and look for products marked "non-comedogenic." Don't sleep with your makeup on -- let your skin breathe and don't share makeup with your friends.

For more information and tips on how to treat your acne and maintain beautiful, clear skin in time for prom night, visit www.acneheroes.com .

About BenzaClin(R)

BenzaClin(R) is proven effective in treating many kinds of acne, including whiteheads, blackheads, and pimples. In clinical trials, BenzaClin(R) worked better than either clindamycin or benzoyl peroxide alone for the topical treatment of acne. With BenzaClin(R), improvements have been shown to occur in as early as two weeks.

BenzaClin(R) is indicated for the topical treatment of acne.

Important Safety Information

IMPORTANT SAFETY INFORMATION

BenzaClin(R) was studied in mild to moderate acne patients. BenzaClin(R) is an acne product you can get with a doctor's prescription. Side effects are usually limited to the skin and include dry skin, itching, peeling, redness and sunburn. Also, clindamycin, an ingredient in BenzaClin(R), may cause diarrhea. If you experience severe diarrhea, stop using BenzaClin(R) and call your doctor immediately. You should not use BenzaClin(R) if you are allergic to clindamycin, benzoyl peroxide, or the antibiotic lincomycin, or if you have a history of colitis.

Please see full prescribing information at www.benzaclin.com.

About sanofi-aventis

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). For more information, www.sanofi-aventis.us or www.sanofi-aventis.com

Forward Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans" and similar expressions. Although sanofi-aventis' management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in sanofi-aventis' annual report on Form 20-F for the year ended December 31, 2008. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements.

US.CLI.09.02.012

    Contacts
    US: Amy Ba, sanofi-aventis, (908)-981-6563 or amy.ba@sanofi-aventis.com


'/>"/>
SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Autism Science Foundation Launches Operations; New Advocacy Group Will Focus on Non-vaccine-related Autism Research
2. NeuroFocus Appoints Dr. Michael Smith as Partner in Consulting Practice
3. Comprehensive Email Lifecycle Management Focus for Messaging Architects at RSA Conference
4. The ALS Association's 'ALS Across America' Focuses On Staying Positive and Involved
5. Medifocus Inc. Reports Improved Clinical Efficacy for its Phase II, Randomized Clinical Study for the Treatment of Early Stage Breast Cancer Tumors
6. Lumension Webinar Focuses on How to Protect Medical Records, Ensure HIPAA Compliance and Improve Productivity
7. The Ensign Group Successfully Graduates Third Nursing Home From CMS Special Focus Program
8. Shattering Myths: Men, Boys, and Mental Health, the Focus of Eighth Annual Conference Hosted by the Naomi Ruth Cohen Institute for Mental Health Education at The Chicago School of Professional Psychology, May 31
9. New NQF Endorsed Standards Focus on Quality and Patient Experience in Home Health Care
10. Bipartisan Coalition Forms to Call for Chronic Disease to be Key Focus of Health Reform in Connecticut and Nationally
11. Digital album puts focus on kids health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology: